The FDA has requested that Amgen voluntarily withdraw avacopan (Tavneos), a treatment for anti-neutrophil cytoplasmic ...

A South Dakota legislative panel greenlit a bill Tuesday that would protect doctors and pharmacists who issue or fill ...

The FDA Center for Drug Evaluation and Research has accepted a letter of intent for the first biomarker for idiopathic pulmonary fibrosis into its Biomarker Qualification Program, according to a press ...

Rheumatoid arthritis (RA) is a chronic autoimmune condition with symptoms that include pain, stiffness, and swelling in the joints. While medications are the gold standard for RA treatment, many ...

Menopausal patients with rheumatic diseases may benefit from the increased use of hormone therapy in light of the FDA’s recent decision to lift black box warning labels. The FDA initiated the removal ...

Rheumatoid arthritis begins years before pain ever appears, and scientists have now mapped the hidden immune battle that unfolds long before symptoms. By studying people with RA-linked antibodies over ...

Credit: Getty Images The recommendations covered the treatment and management of nonrenal SLE, with lupus nephritis addressed in a separate guideline. The American College of Rheumatology (ACR) issued ...

RA patients experience significant financial distress, with 29% meeting criteria, compared to 15% of NIMSKD patients. Financial distress in RA is linked to decreased quality of life, disease severity, ...

Copyright: © 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies. In the past 5 years, PANLAR ...

Background: Rheumatic heart disease (RHD), a sequela of acute rheumatic fever (ARF), remains as the leading cause of acquired cardiac disease in children, posing a significant burden to health systems ...

Please provide your email address to receive an email when new articles are posted on . Use of GLP-1 receptor agonists in diabetes was associated with reduced risk for RA and gout. No reduction in PsA ...

CHICAGO -- Urgent advice to prescribe alternatives to opioid painkillers doesn't seem to be getting through to clinicians who treat older people with rheumatologic conditions, according to a study ...